Skip to content

Prospective Urban Rural Epidemiology Study

Prospective Urban Rural Epidemiology Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03225586
Acronym
PURE
Enrollment
200000
Registered
2017-07-21
Start date
2002-01-01
Completion date
2030-12-31
Last updated
2024-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cardiovascular Diseases, Communicable Disease, Environmental Exposure, Health Behavior, Injuries, Lung Diseases, Renal Disease, Risk Factor, Cardiovascular

Keywords

Non-communicable Diseases, Risk Factors

Brief summary

To examine the impact of health determinants at the individual (e.g. health related behaviors) and societal level (e.g. environmental factors, health related policy, quality of health systems) on health outcomes (e.g. death, non-communicable disease development) across a range of socioeconomic and health resource settings. Additional components of this study will examine genetic factors for non-communicable diseases. This will be examined both through a cross sectional component, and prospectively (cohort component).

Detailed description

1. To examine the relationship between societal influences and prevalence of risk factors and chronic noncommunicable diseases. Societal determinants are measured by an index of measures from each of the 4 domains of interest: built environment, food and nutrition policy, psychosocial/socioeconomic factors, and tobacco. 2. To examine the relationship between societal determinants and incidence of chronic noncommunicable disease events (e.g. cardiovascular disease, cancer) and on changes in rates of selected risk factors (e.g. smoking) 3. To examine the relationship between health related behaviors (e.g. diet, physical activity, smoking, alcohol) and health outcomes (e.g. death, non-communicable diseases) 4. The quality of health systems across a diverse range of health resource settings, and how this impacts health outcomes 5. Genetic factors for non-communicable diseases

Interventions

None listed

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Heart and Stroke Foundation of Ontario
CollaboratorOTHER
Population Health Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years

Inclusion criteria

* consenting adults between 35-70 years of age

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
incident cardiovascular diseasemean follow up of 10 yearscardiovascular death, stroke, myocardial infarction, heart failure

Secondary

MeasureTime frameDescription
Incident COPDmean follow up of 10 yearsdevelopment of COPD
Incident Asthmamean follow up of 10 yearsdevelopment of asthma
Pneumoniamean follow up of 10 yearshospitalization for pneumonia
Respiratory outcomesmean follow up of 10 yearschange in pulmonary function test
All Cause Hospitalizationsmean follow up of 10 yearsAll cause hospitalizations
incident cancermean follow up of 10 yearstotal and cause specific cancers
All cause and cause specific mortalitymean follow up of 10 yearsdeath from all causes, and cause specific deaths
incident diabetesmean follow up of 10 yearsdevelopment of diabetes
obesitymean follow up of 10 yearsdevelopment of obesity, change in BMI
hypertensionmean follow up of 10 yearsdevelopment of hypertension and changes in blood pressure
incident injuriesmean follow up of 10 yearsassessing fatal and non-fatal injuries due road traffic accidents and falls
Kidney diseasemean follow up of 10 yearsend stage renal disease, dialysis, transplant, changes in renal function

Countries

Argentina, Bangladesh, Brazil, Canada, Chile, China, Colombia, India, Iran, Kazakhstan, Kyrgyzstan, Malaysia, Pakistan, Palestinian Territories, Peru, Philippines, Poland, Russia, Saudi Arabia, South Africa, Sweden, Tanzania, Turkey (Türkiye), United Arab Emirates, Zimbabwe

Contacts

Primary ContactSumathy Rangarajan, MSc
sumathy.rangarajan@phri.ca905-521-2100
Backup ContactJanette Panhuis, BScN, MBA
janette.panhuis@phri.ca905-521-2100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026